Related Experiment Videos
[The lung in antiphospholipid syndrome]
G Espinosa1, R Cervera, J Font
1Servicio de Enfermedades Autoinmunes. Instituto Clínico de Infecciones e Inmunología, Hospital Clínic, Barcelona, Spain.
Archivos De Bronconeumologia
|January 26, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients.
Medicina (Kaunas, Lithuania)·2023
Serological autoimmune profile of systemic lupus erythematosus in deep and non-deep endometriosis patients.
Journal of reproductive immunology·2023
Patients with laboratory criteria of anti-phospholipid syndrome and 'non-criteria' manifestations: a multicenter cohort.
Scandinavian journal of rheumatology·2022
Simulation of alpha particle emitted by <sup>222</sup>Rn from natural spring water in Puebla, México.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2022
Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants.
Journal of nanobiotechnology·2022
Cone-Beam CT-Assisted Electromagnetic Navigation Bronchoscopy for Challenging Peripheral Pulmonary Lesions.
Archivos de bronconeumologia·2026
Severe OSA May Be Associated With Endothelial Dysfunction in Patients With Nocturnal Hypertension.
Archivos de bronconeumologia·2026
Advances in Sarcoidosis.
Archivos de bronconeumologia·2026
Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update.
Archivos de bronconeumologia·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026